Malignant Skin Neoplasm — Trials

Malignant Skin Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 320
Recruiting: 171
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (202)

clinicaltrialsPublishedShowing 101–150 of 238 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02385214	MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma(MelMarT)	active not recruiting	N/A	400	Melanoma and Skin Cancer Trials LimitedOTHER	5	Nov 27, 2024	clinicaltrials
NCT03860883	Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma(MelMarT-II)	recruiting	N/A	2,998	Melanoma and Skin Cancer Trials LimitedOTHER